Asia Insurance Post
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
Select Page

Berkshire Hathaway Specialty Insurance Names Idie Si as Head of Accident & Health Insurance, Asia

by AIP Online Bureau | Apr 13, 2021 | International News, Non-Life, Reinsurance

BOSTON & SINGAPORE: Berkshire Hathaway Specialty Insurance (BHSI) today announced that it has appointed Idie Si as Head of Accident & Health (A&H) Insurance for the region.“We are pleased to welcome Idie to BHSI. Her in-depth knowledge, vast...

7% growth in global reinsurance capital in 2020, combined ratios improve: Willis Re

by AIP Online Bureau | Apr 13, 2021 | International News, Non-Life, Reinsurance

  London: Total capital dedicated to the global reinsurance industry measured USD 658 billion at year-end 2020 reflecting 7% year-on-year growth. The rise was driven primarily by strong investment market appreciation. New capital raised both by incumbents and new...

Aon, seeking EU nod on $30 billion Willis bid, offers to sell assets

by AIP Online Bureau | Apr 13, 2021 | Intermediaries, International News, Non-Life

  BRUSSELS: Insurance broker Aon has offered to sell assets in several EU countries and the reinsurance unit of takeover target Willis Towers Watson to gain EU antitrust approval for its $30 billion acquisition bid, a person familiar with the matter said on...

India likely to get average monsoon rains in 2021 – Skymet

by AIP Online Bureau | Apr 13, 2021 | Eco/Invest/Demography, Indian News

NEW DELHI: India is likely to get average monsoon rains this year, a private weather forecasting agency said on Tuesday, raising prospects of higher farm and economic growth in Asia’s third-biggest economy. Monsoon rains are expected to be 103% of a long-term...

India, overwhelmed by COVID surge, fast-tracks approval for foreign vaccines

by AIP Online Bureau | Apr 13, 2021 | Eco/Invest/Demography, Health, Indian News, Non-Life, Pandemic

  New Delhi: India is to fast-track emergency approvals for COVID-19 vaccines that have been authorised by Western countries and Japan, paving the way for possible imports of Pfizer, Johnson & Johnson, and Moderna shots. The move, which will drop the need for...
« Older Entries
Next Entries »

Recent Posts

  • (no title)
  • (no title)
  • President Trump and his team discusing Iran’s proposal to end war
  • Moody’s upgrades Peak Re’s rating to A3 with Stable Outlook
  • EIP partners with Nexacore, launches end-to-end device protection to Southeast Asia

Categories

  • Articles
  • Banking & Bancassurance
  • Blog
  • Breaking News!
  • Briefs
  • Climate, Environment, Renewable Energy
  • Data
  • Disaster & Management
  • Eco/Invest/Demography
  • Editorial
  • Events
  • Facts
  • Features
  • Health
  • Indian News
  • Intermediaries
  • International News
  • Interviews
  • Life
  • Main Menu
  • Non-Life
  • Pandemic
  • Pension & Social Security
  • Policy
  • Regulation
  • Reinsurance
  • Risk Management
  • Simple
  • Technology
  • Trends, Facts
  • Uncategorized
  • Wealth Management/ Philanthropy
  • Workplace/Employee Benefits
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
  • Eco/Invest/Demography
  • Indian News
  • International News
  • Health
  • Non-Life
  • Pandemic
  • Technology
  • Risk Management
  • Reinsurance
  • Banking & Bancassurance
  • Wealth Management/ Philanthropy